BIOEXOTEC’s Post

Attending #ESMO is an inspiring reminder of the profound impact data can have on patients’ lives. The breakthroughs shared represent more than just scientific progress—they hold the power to transform cancer care, offering new hope and better outcomes for millions around the world. Each study, each new insight, takes us one step closer to rethinking how we approach cancer treatment, from early diagnosis to advanced therapies. The data presented here fuels innovation, giving us the tools to challenge the status quo and push for better, more personalized care. At #AstraZeneca, we are leading this charge, pushing boundaries and driving meaningful change. Together, with our partners and peers at ESMO, we are advancing treatments, expanding access to care, and most importantly, changing lives for the better. Every step forward here is a step toward a future filled with hope and possibility. #ESMO2024 #AstraZeneca #OncologyInnovation #HopeForPatients #ChangingLivesThroughScience

🌟 Advancing Precision Medicine Together: A Call to Action 🌟 At BioLens, we believe that collaboration is the key to unlocking the full potential of precision medicine. Research institutes, cancer alliances, and cancer centers are on the frontlines of transforming cancer care, and we want to partner with you to make a meaningful impact. By joining forces with us, you can generate valuable insights that drive innovation in precision medicine, while also creating new revenue streams for your institution. Through our unique partnership model, we share the revenue generated from licensing patient data for research purposes, so your valuable data not only contributes to groundbreaking discoveries but also supports your ongoing mission. 🔬 Together, we can: Harness the power of real-world data to fuel cutting-edge cancer research Advance personalized treatment plans that save lives Reduce upfront costs and grow your resources through a revenue-sharing model Your data holds the power to transform the future of cancer treatment—and with BioLens, you can be a driving force behind the next generation of life-saving innovations. Let’s work together to create a healthier tomorrow, today. Join us in advancing precision medicine and making a lasting impact. 💡 Together, we can make a difference. #PrecisionMedicine #CancerResearch #LifeSciences #DataPartnerships #InnovativeResearch #BioLens #AdvancingCare #CancerAlliance #CancerCenters #ResearchPartnerships #PersonalizedMedicine

Great news! Our CEO, Sean A. MacDonald, will be participating in the highly anticipated LSX World Congress, taking place this April 29-30 in London, UK! Don't miss Sean'presentation on Monday as he will share Domain Therapeutics' exciting advancements in precision medicine for cancer treatment. At Domain, we're not just pioneering innovative therapies. We're redefining what's possible in the fight against cancer. Through our unwavering commitment to leveraging G Protein-Coupled Receptors (GPCRs) in immuno-oncology, we unlock new possibilities to beat resistance and defeat cancer. If you'll be participating in this premier gathering of industry leaders and investors, don't miss this valuable opportunity to connect with Sean and discuss Domain Therapeutics' very hot targets and our innovative approach to cancer therapy. Let's ignite conversations, forge partnerships, and drive global innovation in healthcare together. See you at LSX - partnering for Life Science eXecutives World Congress! #PrecisionMedicine #Immunooncology #Biotech #Innovation #Fundraising

🚀 #SITC24 kicks off tomorrow in Houston, and ANIM8 LLC is excited to be on the ground, diving into cutting-edge advancements in Immuno-Oncology! 🎯 Cancer is a global challenge that won't be solved by one clinical trial or a single company — collaboration is the key to unlocking breakthroughs. That's why we're here to connect with the brightest minds across the IO space to help accelerate progress toward next-generation anticancer therapies. Our CEO & Founder, Raphaël G. Ognar, MSc MBA, and CMO, Debora Barton, MD, will be in the heart of the action. 🤝 If you're attending #SITC24, let’s meet up and explore how we can push the fast forward button on the fight against cancer! 💡 Together, we can make a difference. Let’s ensure that your next step is the right one on the path to success. 🔗 DM us to schedule a meeting, or simply drop a comment below—we’d love to connect! 👇 #ImmunoOncology #CancerResearch #CollaborationForCures #BiotechInnovation #Oncology #SITC2024 #CellAndGeneTherapy

🚨 SPECIAL TRACK: Disrupting Cancer Screening – Boosting Engagement and Participation 🚨 💡 How can we rethink cancer screening and motivate high-risk groups to take action? This special track, powered by our sponsors Roche Lietuva, is calling for disruptive, tech-driven solutions that break barriers and make cancer screening accessible to everyone. Let's change the game in public outreach and build trust with innovative, scalable interventions! 🚀 🧬 Big thanks to #Roche for sponsoring Hospiton! As a global pioneer in pharmaceuticals and diagnostics, they’re committed to advancing healthcare solutions that improve and save lives. We are more than happy to have innovative such an companies in our friends list! Ready to disrupt the status quo? 💥 Join the challenge and make an impact! Register: hospiton.lt Seats are limited, so do not wait till the last minute! #Hospiton2024 #CancelCancer #CancerScreening #Innovation #HealthcareRevolution #ThankYouRoche #DisruptCancer #TechForGood #HealthcareInnovation #SaveLives #EarlyDetection #RocheSponsorship #SpecialTrack

Ready to Rewrite the Future of Cancer: Invest in New Phase's Groundbreaking Technology. We all know someone whose life has been forever altered by cancer. The pain, the fear, the loss – it's a reality that continues to affect countless families, especially for those with a Stage IV diagnosis. New Phase's Technology is not just another treatment – it’s a potential game-changer with the power to transform Stage IV cancer from a devastating diagnosis into a manageable condition. By investing in New Phase, you're not just investing in a company; you're investing in a future where cancer no longer holds the power it once did. You're investing in a legacy of hope and a potential cure. You’re investing to help us make progress in our clinical trials in order to make this technology available to the patients, and for the investors to see their investments pays off, as many successful oncology startups gain high value already in the clinical stage. Ready to make a tangible difference in the fight against one of humanity’s most formidable foes? Contact Email info@newphase.co.il or DM Irie Meltzer, our VP Business Development. #ImpactInvesting #CancerResearch #SavingLives #NewPhase

By investing in New Phase, you are investing in a future💫

Primaa just announced the completion of a €5 million fundraising round! 🚀 I really want to thank all the people who made this possible, and in particular our #investors, the #pathologists we work with and especially the Primaa #team who move mountains 🥰 And now what's next ? This funding strengthens our mission to transform cancer diagnostics worldwide and ensures more patients benefit from our product Celo #Breast #Skin #Prostate #Cervix 🔬 Primaa will be able to go faster, higher, stronger in AI in #digitalpathology. Primaa will thus remain at the forefront of AI and health #innovation I can't wait to see the Primaa journey develop even further 😀 #startup #fundraising #AIinHealthcare

Throughout history, we’ve seen that real innovation doesn’t just come from giving people rewards 🏆; it happens when we create spaces where ideas can connect & grow. 💡🌱 Recently, Exact Sciences & Fight Colorectal Cancer brought together colorectal cancer experts & advocates from all over the country in Madison, WI, for an exciting Innovation Summit. This event was more than just a meeting; it was a chance for change-makers to work together, share ideas, & inspire each other to improve awareness & equity in colorectal cancer. I personally left today feeling motivated & celebrated, but also thankful for the reminder of an important life lesson: if the only tool you have is a hammer 🔨 , you might see every problem as a nail. This idea is very important as we work to improve #ColorectalCancer equity in our communities. To make an impact, who should you be connected to that has tools you don’t? Learning & innovation go hand in hand. We must remember that what worked yesterday may not be enough for tomorrow. As we move forward from this important meeting, keep an eye out for the exciting new ideas that will come from our teamwork. #CRCInnovationSummit

👇 An excellent example of how advancements in early lung cancer diagnostics enhance detection rates and accessibility. Susan Tousi’s leadership and DELFI Diagnostics FirstLook test, leverages whole-genome sequencing and machine learning, paving the way for more accessible, early-stage diagnostics.  #LungCancerAwareness #CancerDetection #Diagnostics